SecurityGSK / GlaxoSmithKline plc
InstitutionMontag A & Associates Inc
Shares5,655
Value $ 228,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Montag A & Associates Inc ownership in GSK / GlaxoSmithKline plc

August 08, 2018 - Montag A & Associates Inc has filed a 13F-HR/A form disclosing ownership of 5,655 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $228,000 USD as of June 30, 2018. Montag A & Associates Inc had filed a previous 13F-HR on May 07, 2018 disclosing 5,655 shares of GlaxoSmithKline plc at a value of $221,000 USD. This represents a change in shares of 0.00 percent and a change in value of 3.17 percent during the quarter.

Other investors with positions similar to Montag A & Associates Inc include Roffman Miller Associates Inc /pa/, Bailard, Inc., Buckley Wealth Management, Llc, Cadinha & Co Llc, Chevy Chase Trust Holdings, Inc., and Wsfs Capital Management, Llc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR/A-1 GLAXOSMITHKLINE PLC ADR FOR 37733W105 39.70 5,655 0.00 228 3.17 0 7 3.17
2018-06-30 13F-HR GLAXOSMITHKLINE PLC ADR FOR 37733W105 5,655 228
2018-03-31 13F-HR GLAXOSMITHKLINE PLC ADR FOR 37733W105 5,655 221 221 0
2014-09-30 13F-HR GLAXOSMITHKLINE PLC ADR FOR 37733W105 0 -100.00 0 -100.00 0 0
2014-06-30 13F-HR GLAXOSMITHKLINE PLC ADR FOR 37733W105 4,290 229


CUSIP: 37733W105